Drug application
NAFCILLIN SODIUM (NAFCILLIN SODIUM)
Drugs@FDA ANDA 063008 · WATSON LABS INC
Key facts
| Drug name | NAFCILLIN SODIUM |
|---|---|
| Active ingredients | NAFCILLIN SODIUM |
| Application type | ANDA |
| Application number | 063008 |
| Company | WATSON LABS INC |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 10GM BASE/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Sep 29, 1988 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.